Traders Bet on October Anthropic IPO Despite Roadshow Delays

SAN FRANCISCO — Market participants on the prediction platform Polymarket are pricing an October stock market listing for artificial intelligence developer Anthropic as the most likely outcome, even as the company faces significant delays to its formal investor roadshow. The betting activity reflects a divergence between public scheduling hurdles and private sector expectations regarding the startup's path to becoming a publicly traded entity.

Anthropic, a leading firm in the development of large language models, has encountered logistical headwinds that have pushed back its timeline for a formal prospectus filing. The primary obstacle involves ongoing negotiations concerning a $15 billion revolving credit facility. These financial discussions, critical for stabilizing the company's balance sheet prior to an initial public offering, have not yet reached a final agreement. Consequently, the scheduled roadshow, where executives typically pitch shares to institutional investors, has been postponed.

Despite these setbacks, sentiment among Polymarket traders remains focused on an October debut. The platform's pricing mechanism indicates that market participants believe the company will resolve its financing hurdles in time for a fourth-quarter listing. This optimism persists even as the delay suggests a compressed timeline for regulatory approvals and final capital structuring.

Major financial institutions are deeply involved in the surrounding ecosystem. Goldman Sachs, JPMorgan Chase, and Morgan Stanley are positioned to play key roles in facilitating the potential offering, given their extensive history underwriting technology sector listings. While specific mandates or lead underwriter designations have not been publicly confirmed, the involvement of these firms is consistent with the scale of a $15 billion credit facility negotiation and a high-profile IPO.

The delay in the prospectus filing creates uncertainty regarding whether an October listing is feasible. Regulatory bodies typically require a finalized prospectus well in advance of a pricing date to ensure investor disclosure standards are met. If the credit facility agreement remains unresolved, the roadshow could slip further into late 2026 or early 2027, potentially invalidating the current market consensus.

Investors are now watching for signs of progress in the financing talks. The resolution of the $15 billion credit line is the immediate prerequisite for moving forward with the public offering. Until a definitive agreement is announced, the October target remains a projection based on trader sentiment rather than confirmed corporate scheduling. The coming weeks will be critical in determining whether Anthropic can bridge the gap between its current delays and the ambitious timeline currently priced by the market.